Watchlist Price Alert

GT Biopharma Inc. (GTBP)

NASDAQ: GTBP · Real-Time Price · USD

2.83

-0.01 (-0.35%)

At close: Jun 16, 2025, 3:26 PM

GT Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-13.16M	-7.6M	-20.88M	-58.01M	-28.3M	-38.65M	-259.19M	-143.25M	21.03M
Depreciation & Amortization	n/a	n/a	n/a	n/a	317K	4K	7K	2K	1K
Stock-Based Compensation	230K	2.2M	7.65M	33.93M	269K	5.31M	9.7M	130.12M	6.59M
Other Working Capital	-109K	-137K	41K	863K	3.24M	-216K	-25K	1.41M	1.93M
Other Non-Cash Items	-800K	-5.28M	10K	538K	18.36M	1.65M	10.18M	1.37M	1.7M
Deferred Income Tax	n/a	n/a	n/a	n/a	-317K	25.09M	228.51M	4.91M	-34.06M
Change in Working Capital	828K	1.82M	-1.99M	7.94M	2.4M	2.94M	111K	1.41M	2.81M
Operating Cash Flow	-12.9M	-8.85M	-15.22M	-15.61M	-7.26M	-3.66M	-10.68M	-5.43M	-1.93M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	-36K	-4K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	200K	n/a	n/a	n/a
Purchase of Investments	12.89M	n/a	12.14M	-23.04M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	12.14M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	12.89M	-2.01M	-12.14M	-23.04K	n/a	200.00	-36K	n/a	-1K
Investing Cash Flow	12.89M	-2.01M	12.14M	-23.04M	n/a	200K	-36K	-4K	-1K
Debt Repayment	n/a	n/a	n/a	1.21M	n/a	3.43M	10.73M	5.99M	1.9M
Common Stock Repurchased	n/a	n/a	-224K	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	16.43M	12.53M	n/a	-533K	n/a	n/a
Financial Cash Flow	2.98M	6.27M	-224K	42.32M	12.53M	3.43M	10.2M	5.99M	1.9M
Net Cash Flow	2.96M	-4.59M	-3.3M	3.67M	5.27M	-32K	-516K	557K	-28K
Free Cash Flow	-12.9M	-8.85M	-15.22M	-15.61M	-7.26M	-3.66M	-10.71M	-5.43M	-1.93M